Resumen
The management of secondary acute myeloid leukemia (s-AML) is challenging because its characteristics predict a poor prognosis. In Colombia, there is a paucity of evidence regarding outcomes in this subgroup of patients.
| Idioma original | Inglés |
|---|---|
| Publicación | Clinical Lymphoma, Myeloma and Leukemia |
| DOI | |
| Estado | Publicada - 1 sept 2023 |
Palabras clave
- AML
- acute myeloid leukemia
- secondary acute myeloid leukemia
- survival
- Colombia
- HSCT
- allo-HSCT
Líneas de Investigación UNAB
- Medicina Interna
Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver